Isis Pharmaceuticals Inc

Regulus Therapeutics Inc.

10% Owner

Avg. Two Year Performance

59% Avg. Purchase Return 26% Compound

82% Avg. Sale Return 35% Compound

Holdings: 5.17M shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Major

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions